AbCellera Biologics, Inc. (ABCL)
11.78
+1.17
(+11.03%)
USD |
NASDAQ |
Aug 25, 09:52
AbCellera Biologics Shareholders Equity (Quarterly) : 896.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 896.02M |
| March 31, 2026 | 938.08M |
| December 31, 2025 | 966.90M |
| September 30, 2025 | 964.04M |
| June 30, 2025 | 1.007B |
| March 31, 2025 | 1.023B |
| December 31, 2024 | 1.056B |
| September 30, 2024 | 1.078B |
| June 30, 2024 | 1.111B |
| March 31, 2024 | 1.130B |
| December 31, 2023 | 1.152B |
| September 30, 2023 | 1.183B |
| June 30, 2023 | 1.195B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.208B |
| December 31, 2022 | 1.233B |
| September 30, 2022 | 1.250B |
| June 30, 2022 | 1.213B |
| March 31, 2022 | 1.208B |
| December 31, 2021 | 1.026B |
| September 30, 2021 | 953.40M |
| June 30, 2021 | 967.68M |
| March 31, 2021 | 957.12M |
| December 31, 2020 | 830.51M |
| September 30, 2020 | 89.24M |
| June 30, 2020 | 90.89M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 4.802B |
| Danaher Corp. | 52.58B |
| Illumina, Inc. | 2.838B |
| Bio-Techne Corp. | 2.108B |
| Waters Corp. | 15.20B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.308B |
| Total Liabilities (Quarterly) | 233.30M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 12.77 |
| Net Debt Paydown Yield | -0.56% |